{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:45Z","timestamp":1781927565059,"version":"3.54.5"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.2169\/internalmedicine.5972-25","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:07:08Z","timestamp":1762985228000},"page":"1637-1642","source":"Crossref","is-referenced-by-count":3,"title":["Cardiomyopathy Associated with Subclinical Becker Muscular Dystrophy in a Patient Presenting with Anesthesia-induced Rhabdomyolysis"],"prefix":"10.2169","volume":"65","author":[{"given":"Kento","family":"Kumai","sequence":"first","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ohta-Ogo","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Omics Research Center, National Cerebral and Cardiovascular Center, Japan"},{"name":"Veterinary Teaching Hospital, Joint Faculty of Veterinary Medicine, Kagoshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuki","family":"Nagatomo","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Kawauchi","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Shiomura","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Seguchi","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"},{"name":"Nagaya Internal Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinta","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomasa","family":"Makita","sequence":"additional","affiliation":[{"name":"Omics Research Center, National Cerebral and Cardiovascular Center, Japan"},{"name":"Department of Cardiology, Sapporo Teishinkai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kingston HM, Sarfarazi M, Thomas NS, Harper PS. Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet 67: 6-17, 1984.","DOI":"10.1007\/BF00270551"},{"key":"2","unstructured":"2. Koenig M, Beggs AH, Moyer M, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45: 498-506, 1989."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Melacini P, Fanin M, Danieli GA, et al. Myocardial involvement is very frequent among patients affected with subclinical Becker&apos;s muscular dystrophy. Circulation 94: 3168-3175, 1996.","DOI":"10.1161\/01.CIR.94.12.3168"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hoogerwaard EM, de Voogt WG, Wilde AA, et al. Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol 244: 657-663, 1997.","DOI":"10.1007\/s004150050163"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hayes J, Veyckemans F, Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth 18: 100-106, 2008.","DOI":"10.1111\/j.1460-9592.2007.02302.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Segura LG, Lorenz JD, Weingarten TN, et al. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures. Paediatr Anaesth 23: 855-864, 2013.","DOI":"10.1111\/pan.12248"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Clemens PR, Niizawa G, Feng J, et al. The CINRG Becker natural history study: baseline characteristics. Muscle Nerve 62: 369-376, 2020.","DOI":"10.1002\/mus.27011"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakamura A, Matsumura T, Ogata K, et al. Natural history of Becker muscular dystrophy: a multicenter study of 225 patients. Ann Clin Transl Neurol 10: 2360-2372, 2023.","DOI":"10.1002\/acn3.51925"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. van de Velde NM, Koeks Z, Signorelli M, et al. Longitudinal assessment of creatine kinase, creatine\/creatinine<sub>ratio<\/sub>, and myostatin as monitoring biomarkers in Becker muscular dystrophy. Neurology 100: e975-e984, 2023.","DOI":"10.1212\/WNL.0000000000201609"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yilmaz A, Gdynia HJ, Baccouche H, et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10: 50, 2008.","DOI":"10.1186\/1532-429X-10-50"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Puchalski MD, Williams RV, Askovich B, et al. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging 25: 57-63, 2009.","DOI":"10.1007\/s10554-008-9352-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Silva MC, Magalhaes TA, Meira ZM, et al. Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol 2: 190-199, 2017.","DOI":"10.1001\/jamacardio.2016.4801"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Raman SV, Hor KN, Mazur W, et al. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 14: 153-161, 2015.","DOI":"10.1016\/S1474-4422(14)70318-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Raman SV, Hor KN, Mazur W, et al. Stabilization of early Duchenne cardiomyopathy with aldosterone inhibition: results of the multicenter AIDMD trial. J Am Heart Assoc 8: e013501, 2019.","DOI":"10.1161\/JAHA.119.013501"},{"key":"15","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1161\/CIR.0000000000000526","volume":"136","author":"B Feingold","year":"2017","unstructured":"15. Feingold B, Mahle WT, Auerbach S, et al. Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association. Circulation 136: e200-e231, 2017.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kajimoto H, Ishigaki K, Okumura K, et al. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 70: 991-994, 2006.","DOI":"10.1253\/circj.70.991"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ogata H, Ishikawa Y, Ishikawa Y, Minami R. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 53: 72-78, 2009.","DOI":"10.1016\/j.jjcc.2008.08.013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M. Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 49: 1357-1363, 2010.","DOI":"10.2169\/internalmedicine.49.3259"},{"key":"19","unstructured":"19. Palladino A, Papa AA, Morra S, et al. Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results. Acta Myol 38: 1-7, 2019."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Seguchi O, Kuroda K, Fujita T, Fukushima N, Nakatani T. Advanced heart failure secondary to muscular dystrophy: clinical outcomes after left ventricular assist device implantation. J Heart Lung Transplant 35: 831-834, 2016.","DOI":"10.1016\/j.healun.2016.01.017"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Miller ED Jr., Sanders DB, Rowlingson JC, Berry FA Jr., Sussman MD, Epstein RM. Anesthesia-induced rhabdomyolysis in a patient with Duchenne&apos;s muscular dystrophy. Anesthesiology 48: 146-148, 1978.","DOI":"10.1097\/00000542-197802000-00012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Obata R, Yasumi Y, Suzuki A, Nakajima Y, Sato S. Rhabdomyolysis in association with Duchenne&apos;s muscular dystrophy. Can J Anaesth 46: 564-566, 1999.","DOI":"10.1007\/BF03013547"},{"key":"23","unstructured":"23. Takahashi H, Shimokawa M, Sha K, et al. Sevoflurane can induce rhabdomyolysis in Duchenne&apos;s muscular dystrophy. Masui (Jpn J Anesthesiol) 51: 190-192, 2002 (in Japanese)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schieren M, Defosse J, B\u00f6hmer A, Wappler F, Gerbershagen MU. Anaesthetic management of patients with myopathies. Eur J Anaesthesiol 34: 641-649, 2017.","DOI":"10.1097\/EJA.0000000000000672"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2: 90-95, 1988.","DOI":"10.1016\/0888-7543(88)90113-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Li X, Zhao L, Zhou S, et al. A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China. Orphanet J Rare Dis 10: 5, 2015.","DOI":"10.1186\/s13023-014-0220-7"},{"key":"27","unstructured":"27. Moore RS, Tirupathi S, Herron B, Sands A, Morrison PJ. Dystrophin exon 29 nonsense mutations cause a variably mild phenotype. Ulster Med J 86: 185-188, 2017."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Okubo M, Goto K, Komaki H, et al. Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan. Orphanet J Rare Dis 12: 149, 2017.","DOI":"10.1186\/s13023-017-0703-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Torella A, Zanobio M, Zeuli R, et al. The position of nonsense mutations can predict the phenotype severity: a survey on the DMD gene. PLoS One 15: e0237803, 2020.","DOI":"10.1371\/journal.pone.0237803"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Okubo M, Noguchi S, Hayashi S, et al. Exon skipping induced by nonsense\/frameshift mutations in DMD gene results in Becker muscular dystrophy. Hum Genet 139: 247-255, 2020.","DOI":"10.1007\/s00439-019-02107-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Franz WM, Cremer M, Herrmann R, et al. X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene. Ann N Y Acad Sci 752: 470-491, 1995.","DOI":"10.1111\/j.1749-6632.1995.tb17457.x"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Franz WM, M\u00fcller M, M\u00fcller OJ, et al. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet 355: 1781-1785, 2000.","DOI":"10.1016\/S0140-6736(00)02266-2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_5972-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:36Z","timestamp":1781926656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/12\/65_5972-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5972-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"5972-25"}}